医疗服务公司The Pennant Group, Inc.(PNTG)周二盘中股价大跌12.38%,报收于31.42美元。这主要是由于该公司公布的2024年第三季度盈利虽然好于市场预期,但未能带来太大惊喜。
公司在当天公布了截至2024年9月30日的季度业绩报告,营收同比增长28.9%至1.81亿美元,超出分析师平均预期的1.75亿美元。调整后每股收益为0.26美元,高于分析师预期的0.23美元,但仅略高于去年同期的0.20美元。
虽然连续多个季度创下盈利纪录,但投资者似乎对于业绩增长放缓感到失望。过去三个月里,分析师对该公司的盈利预期已下调2.1%。不过,该公司目前被华尔街机构普遍评级为"买入",主要缘于其在老年人口持续增长的大背景下,潜在的业务增长空间。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.